ArticleFrontiers in immunology2025

SLC43A2-mediated immune cell infiltration: a potential therapeutic target in acute myeloid leukemia.

Mengnan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.